Heritability for Autism Spectrum Disorder Varies for Males and Females
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 17, 2024 -- Heritability for autism spectrum disorder (ASD) varies for males and females, with higher heritability seen for males than females, according to a study published online April 17 in JAMA Psychiatry.
Sven Sandin, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues estimated the sex-specific heritability of ASD in a population-based, retrospective analysis of nontwin siblings and cousins from Sweden born between Jan. 1, 1985, and Dec. 31, 1998, with follow-up to age 19 years. The relative variance in risk for ASD occurrence due to sex-specific additive genetics, shared environmental effects, and a common residual term, which conceptually captured other factors that promote individual behavioral variation, was estimated.
The sample included 1,047,649 individuals in 456,832 families. The researchers found that 1.17 percent of the entire sample received a diagnosis of ASD, including 1.51 percent of males and 0.80 percent of females. For males and females, ASD heritability was estimated at 87.0 and 75.7 percent, respectively, with the difference in heritability estimated at 11.3 percent. No support was seen for shared environmental contributions.
"The skewed sex ratio in ASD may, partly, be explained by differences in genetic variance between sexes," the authors write. "This discovery opens up new avenues for further research aimed at gaining a deeper understanding of the prevalence of ASD."
One author received a grant from BioMarin.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...
American College of Surgeons, Oct. 19-22
The annual meeting of the American College of Surgeons was held this year from Oct. 19 to 22 in San Francisco and attracted participants from around the world, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.